» Authors » Christine Undseth

Christine Undseth

Explore the profile of Christine Undseth including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 94
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Acosta Roa A, Skingen V, Rekstad B, Undseth C, Rusten E, Hernes E, et al.
Phys Med . 2023 Oct; 114:103151. PMID: 37813051
Purpose: To evaluate the variability of the 18F-FDG-PET/CT-based metabolic tumor volume (MTV) in anal cancers during fractionated chemoradiotherapy (CRT), and assess the impact of this variability on dosimetric accuracy in...
2.
Nilsson M, Undseth C, Albertsson P, Eidem M, Mayland Havelund B, Johannsson J, et al.
Acta Oncol . 2023 Jul; 62(8):897-906. PMID: 37504978
To date, anal cancer patients are treated with radiotherapy to similar volumes despite a marked difference in risk profile based on tumor location and stage. A more individualized approach to...
3.
Groendahl A, Moe Y, Kaushal C, Huynh B, Rusten E, Tomic O, et al.
Acta Oncol . 2021 Nov; 61(1):89-96. PMID: 34783610
Background: Accurate target volume delineation is a prerequisite for high-precision radiotherapy. However, manual delineation is resource-demanding and prone to interobserver variation. An automatic delineation approach could potentially save time and...
4.
Slordahl K, Klotz D, Olsen J, Skovlund E, Undseth C, Abildgaard H, et al.
Acta Oncol . 2021 May; 60(7):921-930. PMID: 33966592
Background: Squamous cell carcinoma of the anus (SCCA) is a rare malignancy with rising incidence, associated with human papilloma virus (HPV). Chemoradiotherapy (CRT) is the preferred treatment. The purpose was...
5.
Al-Haidari G, Skovlund E, Undseth C, Rekstad B, Larsen S, Asli L, et al.
Acta Oncol . 2020 Feb; 59(5):534-540. PMID: 32056476
There is no clear consensus on the use of re-irradiation (reRT) in the management of locally recurrent rectal cancer (LRRC). The aim of the present study was to investigate all...
6.
Rusten E, Rekstad B, Undseth C, Klotz D, Hernes E, Guren M, et al.
Br J Radiol . 2019 Feb; 92(1097):20181006. PMID: 30810343
Objective: To assess the role of [F]fluorodeoxyglucose (FDG) positron emission tomography (PET), obtained before and during chemoradiotherapy, in predicting locoregional failure relative to clinicopathological factors for patients with anal cancer....
7.
Rusten E, Rekstad B, Undseth C, Al-Haidari G, Hanekamp B, Hernes E, et al.
Radiat Oncol . 2017 Sep; 12(1):147. PMID: 28874205
Purpose: To compare target volume delineation of anal cancer using positron emission tomography (PET) and magnetic resonance imaging (MRI) with respect to inter-observer and inter-modality variability. Methods: Nineteen patients with...
8.
Cameron M, Kersten C, Vistad I, van Helvoirt R, Weyde K, Undseth C, et al.
Acta Oncol . 2016 Jun; 55(12):1400-1407. PMID: 27332723
Background And Purpose: Palliative pelvic radiotherapy (PPRT) is used to treat locally advanced rectal cancer (RC) although symptomatic effects and toxicities are poorly documented. Aims were to evaluate symptom severity,...
9.
Gronlie Cameron M, Kersten C, Vistad I, van Helvoirt R, Weyde K, Undseth C, et al.
Radiother Oncol . 2015 Jun; 115(3):314-20. PMID: 26091575
Background And Purpose: Radiotherapy is used to palliate pelvic symptoms of castration resistant prostate cancer (CRPC). However, magnitude and time course of effects and toxicities are poorly documented. Study aims...
10.
Guren M, Undseth C, Rekstad B, Braendengen M, Dueland S, Spindler K, et al.
Radiother Oncol . 2015 Jan; 113(2):151-7. PMID: 25613395
Background: Many patients with rectal cancer receive radiotherapy as a component of primary multimodality treatment. Although local recurrence is infrequent, reirradiation may be needed to improve resectability and outcomes. This...